Long-term prognostic value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis

Journal of Nuclear Cardiology

Volumn 23, Issue 2, 2016, Pages 185-197

  Cantoni, Valeria ^a   Green, Roberta ^a   Acampa, Wanda ^b   Petretta, Mario ^a   Bonaduce, Domenico ^a   Salvatore, Marco ^c   Cuocolo, Alberto ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

computed tomography (CT); coronary artery disease; meta analysis; Myocardial perfusion imaging: SPECT; prognosis

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ELECTRON BEAM TOMOGRAPHY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; META ANALYSIS;

COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS;

EID: 84960438997     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0349-3     Document Type: Article

References (43)

1. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.
2. Bamberg F, Sommer WH, Hoffmann V, Achenbach S, Nikolaou K, Conen D, et al. Meta-analysis and systematic review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced coronary computed tomography angiography. J Am Coll Cardiol 2011;57:2426-36.
3. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al.: American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM. Appropriate use criteria for cardiac radionuclide imaging: A Report of the American College of Cardiology Foundation appropriate use criteria task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol 2009;2009:2201-29.
4. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; Society of Cardiovascular Computed Tomography; American College of Radiology; American Heart Association; American Society of Echocardiography; American Society of Nuclear Cardiology; North American Society for Cardiovascular Imaging; Society for Cardiovascular Angiography and Interventions; Society for Cardiovascular Magnetic Resonance. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for cardiovascular magnetic resonance. J Cardiovasc Comput Tomogr 2010;4:407.e1-33.
5. Schuijf JD, Wijns W, Jukema JW, Decramer I, Atsma DE, de Roos A, et al. A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT. J Nucl Med 2006;47:1749-55.
6. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
7. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
11. Cleophas TJ, Zwinderman AH. Meta-analysis. Circulation 2007;115:2870-5.
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
13. Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol 2001;37:1558-64.
14. Galassi AR, Azzarelli S, Tomaselli A, Giosofatto R, Ragusa A, Musumeci S, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001;88:101-6.
15. Schinkel AF, Elhendy A, Van Domburg RT, Bax JJ, Valkema R, Roelandt JR, et al. Long-term prognostic value of dobutamine stress 99 mTc-sestamibi SPECT: Single-center experience with 8-year follow-up. Radiology 2002;225:701-6.
16. Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. J Hypertens 2003;21:1945-51.
17. Kawamura M, Ohta Y, Katoh K, Nishimura S. Medium- to long-term prognostic impact of dipyridamole thallium-201 myocardial single-photon emission computed tomography in elderly patients. Circ J 2003;67:913-7.
18. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, et al. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2005;46:2003-8.
19. Coma-Canella I, Palazuelos J, Bravo N, García Velloso MJ. Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events. J Nucl Cardiol 2006;13:316-23.
20. Ueshima K, Yamashina A, Usami S, Yasuno S, Nishiyama O, Yamazaki T, et al. Prognostic value of myocardial perfusion SPECT images in combination with the maximal heart rate at exercise testing in Japanese patients with suspected ischemic heart disease: A sub-analysis of J-ACCESS. Ann Nucl Med 2009;23:849-54.
21. Acampa W, Petretta M, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: A prospective, multicentre trial. Eur J Nucl Med Mol Imaging 2012;39:387-95.
22. Boiten HJ, van der Sijde JN, Ruitinga PR, Valkema R, Geleijnse ML, Sijbrands EJ, et al. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography. J Nucl Cardiol 2012;19:907-13.
23. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008;52:1335-43.
24. Gopal A, Nasir K, Ahmadi N, Gul K, Tiano J, Flores M, et al. Cardiac computed tomographic angiography in an outpatient setting: An analysis of clinical outcomes over a 40-month period. J Cardiovasc Comput Tomogr 2009;3:90-5.
25. Hadamitzky M, Hein F, Meyer T, Bischoff B, Martinoff S, Schömig A, et al. Prognostic value of coronary computed tomographic angiography in diabetic patients without known coronary artery disease. Diabetes Care 2010;33:1358-63.
26. de Azevedo CF, Hadlich MS, Bezerra SG, Petriz JL, Alves RR, de Souza O. Prognostic value of CT angiography in patients with inconclusive functional stress tests. JACC Cardiovasc. Imaging 2011;4:740-51.
27. Andreini D, Pontone G, Mushtaq S, Bartorelli AL, Bertella E, Antonioli L, et al. A long-term prognostic value of coronary CT angiography in suspected coronary artery disease. JACC Cardiovasc Imaging 2012;5:690-701.
28. Cho I, Shim J, Chang HJ, Sung JM, Hong Y, Shim H, et al. Prognostic value of multidetector coronary computed tomography angiography in relation to exercise electrocardiogram in patients with suspected coronary artery disease. J Am Coll Cardiol 2012;60:2205-15.
29. Yamamoto H, Kitagawa T, Ohashi N, Utsunomiya H, Kunita E, Oka T, et al. Noncalcified atherosclerotic lesions with vulnerable characteristics detected by coronary CT angiography and future coronary events. J Cardiovasc Comput Tomogr 2013;7:192-9.
30. Pontone G, Andreini D, Bartorelli AL, Bertella E, Cortinovis S, Mushtaq S, et al. A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD. JACC Cardiovasc Imaging 2013;6:641-50.
31. Dedic A, Kurata A, Lubbers M, Meijboom WB, van Dalen B, Snelder S, et al. Prognostic implications of non-culprit plaques in acute coronary syndrome: Non-invasive assessment with coronary CT angiography. Eur Heart J Cardiovasc Imaging 2014;15:1231-7.
32. Dougoud S, Fuchs TA, Stehli J, Clerc OF, Buechel RR, Herzog BA, et al. Prognostic value of coronary CT angiography on long-term follow-up of 6.9 years. Int J Cardiovasc Imaging 2014;30:969-76.
33. Park GM, Lee SW, Cho YR, Kim CJ, Cho JS, Park MW, et al. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2014;113:765-71.
34. Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol 2012;19:1026-43.
35. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.
36. Hlatky MA, Shilane D, Hachamovitch R, Dicarli MF. SPARC Investigators. Economic outcomes in the Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease registry: The SPARC Study. J Am Coll Cardiol 2014;63:1002-8.
37. Min JK, Koduru S, Dunning AM, Cole JH, Hines JL, Greenwell D, et al. Coronary CT angiography versus myocardial perfusion imaging for near-term quality of life, cost and radiation exposure: A prospective multicenter randomized pilot trial. J Cardiovasc Comput Tomogr 2012;6:274-83.
38. Shreibati JB, Baker LC, Hlatky MA. Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries. JAMA 2011;306:2128-36.
39. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, PROMISE Investigators, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372:1291-300.
40. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma E, Wijns W, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 2009;53:623-32.
41. Nielsen LH, Ortner N, Nørgaard BL, Achenbach S, Leipsic J, Abdulla J. The diagnostic accuracy and outcomes after coronary computed tomography angiography vs. conventional functional testing in patients with stable angina pectoris: A systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014;15:961-71.
42. Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother 2004;48:2787-92.
43. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials. BMJ 2011;343:d4002.